Company: NDRA
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001654954-25-005770
Chunk: 87

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 2
Chunk 87
---
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 ENDRA LIFE SCIENCES INC.    Date: May 15, 2025By:/s/ Alexander Tokman   Alexander Tokman   Chief Executive Officer and Chairman(Principal Executive Officer) 

 ENDRA LIFE SCIENCES INC.     Date: May 15, 2025By:/s/ Richard Jacroux   Richard Jacroux   Chief Financial Officer(Principal Financial and Accounting Officer) 

 24